Obesity can have an adverse impact on health at each stage of a woman's life cycle. In young women, obesity has an impact on psychosocial health and, as they grow older and become parents, on their reproductive health. Obesity also imposes a number of serious risks during pregnancy. In older women, obesity is associated with the emergence of a number of related chronic diseases, such as type 2 diabetes and cardiovascular disease, and increased risk for almost all types of cancer. Of concern in the elderly is the increasing evidence that obesity is an independent risk factor for dementia and Alzheimer's disease. Obesity also has a marked impact on life expectancy. The medical risks associated with obesity in women are also important for the woman's children and future generations. There is emerging evidence that nutrition during fetal and early life can influence risk for obesity and chronic diseases for both sexes. International Journal of Obesity (2007) 31, S3-S7; doi:10.1038/sj.ijo.0803729
In an obesogenic environment, women are at greater risk for obesity, and especially severe obesity, than men, and they also appear to be at disproportionate risk for some of the complications of obesity. In most developed countries, the rates of obesity are higher in women than men. Also, focus on obesity in women is an important consideration for men because the metabolic status of the mother during pregnancy can impact her children, both boys and girls.
The biologic differences between men and women in their risk for obesity and its complications are an important area for research because they can give insights into the mechanisms that underlie obesity and can increase the understanding of obesity in both genders.
Adolescence and young adulthood
Obesity can have an adverse impact on health at each stage of a woman's life. In young women, obesity has an impact on psychosocial health and, as they grow older and become parents, on their reproductive health.
The higher rate of obesity in women compared with men has a number of societal consequences. Compared with men, women suffer more from the stigmatisation imposed by obesity and have lower education levels and rates of marriage. At a socio-economic level, compared with normal weight women, obese women with higher education or in upper white-collar positions have significantly lower incomes. Excess body weight is not associated with similar income disadvantages for men.
The social and economic consequences of obesity were demonstrated in a study of a representative sample of 10 039 US adolescent and young adult men and women (aged 16-24 years). On follow-up 7 years after the initial survey, women who had been overweight (defined as body mass index (BMI) above the 95th percentile for age and sex) at baseline had indices of socio-economic status that were worse than those of the normal weight women. The survey showed that they were more likely to have had fewer years of education, to be living in poverty, to have lower household incomes and they were less likely to be married, independent of baseline socioeconomic status and aptitude test scores. 1 Furthermore, for each of these indices, the difference between overweight and normal weight subjects was more pronounced in women than men ( Figure 1 ). As women enter childbearing years, obesity impacts on reproductive health. Obesity is associated with increased rates of infertility and risk for polycystic ovary syndrome (PCOS). The relationship between adolescent BMI and menstrual irregularity and ovulatory infertility was investigated in the Nurses Health Study. The association between menstrual cycle irregularity from age 18 to 22 and BMI at age 18 was examined in the baseline cohort of over 116 000 women. Ovulatory failure was assessed in a case-control study within the main study: the cases were 2527 married nulliparous nurses who were unable to become pregnant for at least 1 year because of ovulatory disorder (assessed by questionnaire and in some cases by review of medical records); controls were 46 718 married parous nurses with no history of infertility. As shown in Figure 2 , as BMI at age 18 exceeded 25 kg/m 2 , the prevalence of menstrual cycle irregularity increased and the risk of ovulatory failure increased. 2 In this study, about 500 cases of PCOS were reported. In both women with PCOS and women without PCOS, increased BMI was associated with an increased relative risk of infertility. 2 Obese women not only have lower fertility rates, but also have a poorer prognosis with assisted reproduction. An Australian study 3 investigated whether BMI affects the probability of pregnancy in a series of 3586 women who underwent assisted reproduction (in vitro fertilisation, intracytoplasmic sperm injection or gamete intrafallopian transfer). Participants were stratified into five groups according to BMI. As the BMI increased, the chances of becoming pregnant and having a successful pregnancy reduced. 
Obesity in pregnancy
Obesity imposes a number of serious risks during pregnancy. In early pregnancy, medical complications in obese women include increased twinning and a higher rate of miscarriage; in addition, ultrasound can be difficult. During pregnancy, higher rates of pregnancy-induced hypertension and preeclampsia, higher rates of gestational diabetes and higher rates of venous thromboembolism are all associated with obesity. During delivery, obese women are likely to have higher rates for induction of labour, and for planned and acute caesarean section, and higher rates of dystocia and, therefore, of assisted delivery and vaginal tears. There are also associated technical difficulties, with higher rates of infection, bleeding and thrombosis compared with nonobese women who have assisted deliveries and caesarean sections. Anaesthesia poses a further challenge in obese mothers. After delivery, obese women are at increased risk for postpartum haemorrhage and infection, and also at increased risk for venous thromboembolism.
Obesity in pregnancy also confers serious health risks for the foetus. Impaired glucose tolerance (IGT) in the pregnant woman can lead to macrosomia, and there is also an increased risk of congenital abnormalities, foetal distress, perinatal morbidity and mortality. There is also a risk of birth injury.
In 2003, the US Behavioural Risk Factor Surveillance System assessed the rate of obesity in women aged 18-44 years at 19.6%. This is likely to under-report the true rate of obesity, as the data come from a telephone questionnaire survey, in which respondents are likely to over-estimate their height and under-estimate their weight. Obesity is now such a widespread problem that the Institute of Medicine in the United States 4 has made recommendations for weight gain during pregnancy for normal weight, overweight and obese women (Table 1) . There is no comparable uniform recommendation across the European Union for weight gain in pregnancy. The World Health Organization subcommittee on nutrition 5 currently focuses on maternal under-nutrition rather than maternal overweight as a public health priority from a worldwide perspective. However, it is probable that a similar approach to the US on recommendations for weight gain will emerge in the EU as the prevalence of overweight and obesity in young women escalates. Medical risk in obese women D Ryan
Intergenerational programming
One emerging issue of great concern in reproductive health and obesity is the intergenerational implications of childbearing in obese women. There is evidence from epidemiologic and animal studies supporting the nutritional programming of obesity, and other chronic diseases, in foetal and early life. Clearly, since foetuses of both genders are subject to the intrauterine environment, obesity in women in this context can impact both genders. Figure 3 shows a paradigm for intergenerational programming, highlighting how the mother's nutritional status can influence the foetus and can influence the development of obesity in adult life. 6 The implication is that both undernutrition and over-nutritionFassociated with gestational diabetes, maternal obesity and excessive weight gainFincrease the infant's risk of later fatness and the subsequent risk in adulthood of developing obesity, diabetes, hypertension and cardiovascular disease. Gestational diabetes mellitus occurs in around 4% of all pregnancies. In overweight women, the prevalence increases significantly to 17%. Risk estimates of type 2 diabetes after gestational diabetes vary from 17 to 63% over 5-16 years, depending on the ethnic background of the study population and the sensitivity of the detection method used for both type 2 diabetes and gestational diabetes. [7] [8] [9] The emerging evidence from animal studies and human observational studies indicates a need for concern about the maternal-foetal interaction and also the interaction between the mother and infant in early life. This appears to be a critical period of programming that can lead to the development of increased risk for chronic disease. In a study designed to assess the hypothesis that long-term postnatal development may be modified by metabolic experiences in utero, children of women with pregestational diabetes and gestational diabetes were reviewed annually to measure the prevalence of impaired glucose tolerance (IGT). 10 IGT was 1.2% at o5 years, increasing to 5.4% at 5-9 years. By the age of 10-16 years, 19.3% of the children of diabetic mothers had IGT, compared with around 2% in a control group. In other words, the children had 10 times the risk of IGT at a preadolescent age. Further supporting data come from a series of studies carried out in the Gila River Pima Indian Community of Arizona. As part of a longitudinal study of diabetes that has been underway since 1965, Pima Indians undergo an oral glucose tolerance test during pregnancy and their children are studied. This, therefore, represents a well-characterised population to illustrate some of the issues that may underlie nutritional programming and the intergenerational effects that can occur in the maternal-foetal environment. The prevalence of gestational diabetes according to the birth weight of the mother was investigated in one such study. 11 Two groups of women were assessed: those who became pregnant between the ages of 25 and 35, and those who became pregnant much younger between the ages of 15 and 24. Not surprisingly, prevalence of gestational diabetes was higher in the older age group. But in both age groups, there was a U-shaped relationship, with an increased risk of gestational diabetes if the mother's birthweight was less than 2.5 kg or more than 4.5 kg; thus, nutritional programming of the mother was being translated into the second generation.
A relationship has also been observed between prevalence of obesity in children and their mother's metabolic status. Children whose mothers had diabetes during pregnancy had a higher prevalence of obesity than children whose mothers had IGT (prediabetes) or were non-diabetic during pregnancy. At 15-19 years, 58% of the children of diabetics weighed 140% or more of their desirable weight compared with 17% of the children of non-diabetics and 25% of the children of women with prediabetes. 12 The children of diabetic mothers were significantly more obese than those of non-diabetic mothers, regardless of maternal BMI. For the children of non-diabetic or prediabetic mothers, the relationship was also evident when the data were analysed according to the BMI of the mother: for example, in the 15-19 age group, the prevalence of obesity ranged from 19-54% according to the BMI of the mother, with the higher BMIs being associated with higher rates of obesity in the children. It is becoming apparent, therefore, that a woman's nutritional and metabolic status during pregnancy can programme her daughter or son, and in the case of the Medical risk in obese women D Ryan daughter when she reaches childbearing age, she can in turn impose an effect on the next generation. Thus obesity in pregnancy may affect several generations to come and is to be avoided.
Mature and ageing women
As women age, one sees the emergence of obesity-related chronic diseases, such as type 2 diabetes, hypertension and cardiovascular disease. 13 There is also increased risk for several of the major cancers. The effects of obesity on cardiovascular disease are discussed elsewhere in this supplement. The risk of type 2 diabetes is closely linked to weight gain and obesity. Indeed, it is the rising rate of overweight and obesity that is driving the current worldwide epidemic of type 2 diabetes, which has major implications for health-care systems and the costs of care.
However, it is now appreciated that modest intentional weight loss can have a powerful effect in preventing progression to type 2 diabetes in overweight persons at risk. This was demonstrated in the Diabetes Prevention Program, which showed a 58% reduction in conversion from IGT to type 2 diabetes with a lifestyle intervention programme that was associated with a modest weight loss of just 7%. 14 Further analysis of the weight loss status of individuals according to risk reduction for type 2 diabetes shows that most of the diabetes prevention is, in fact, occurring with the first 5-7% weight loss, with additional weight loss not adding a great deal in terms of diabetes prevention. 15 The increased risk for cancer associated with obesity was illustrated in the American Cancer Society study, which followed over 900 000 individuals between 1982 and 1998. Increased body weight was associated with increased death rates for all cancers combined, and for cancers at multiple specific sites. Cancer in women showed significant trends of increasing risk with higher BMI for death from cancers of the breast, uterus, cervix and ovary. 16 
Obesity and the older woman
Of concern in the elderly is the risk that obesity imposes for impaired cognitive function and Alzheimer's disease, and the negative implications that obesity has in terms of life expectancy.
A population-based study of 959 men and women aged 69-78 years found a strong association between the metabolic syndrome (defined according to National Cholesterol Education Program criteria) and the risk for Alzheimer's disease in women (Figure 4 ). The prevalence of probable or possible Alzheimer's disease was 8.3% in women with the metabolic syndrome and 1.9% in women without the metabolic syndrome. The association was not demonstrated in men, in whom the prevalence was 3.8 and 3.9%. 17 However, the sample included few cases of Alzheimer's disease (45 overall) and it also had a smaller sample of men (337 compared with 622 women) and, therefore, the validity of the data in men is not as strong as that in women.
There is emerging evidence that obesity is also an independent risk factor for cognitive dysfunction and Alzheimer's disease. Cross-sectional and longitudinal studies have demonstrated an increased risk for dementia and Alzheimer's disease in obese individuals. In one study of 1449 individuals, obesity (BMI 430 kg/m 2 ) at midlife was associated with increased risk of dementia and Alzheimer's disease in later life, after adjusting for sociodemographic variables. 18 Midlife obesity, high total cholesterol and high systolic blood pressure were all significant risk factors for dementia, and had additive effects. In another study, 392 adults aged 70 without dementia were followed up for 18 years. 19 The findings suggested that overweight at age 70 is a risk factor for dementia, particularly Alzheimer's disease, in women. Dementia risk was associated with a BMI X25 kg/m 2 . BMI was, on average, 3.6 higher among those who developed Alzheimer's disease than those who did not. A similar association was not found in men. In addition, at least one longitudinal study has demonstrated that overweight and obesity are associated with abnormalities in areas of the brain that are associated with Alzheimer's disease, with temporal lobe brain atrophy being observed on computerised tomography scan. 20 
Impact on life expectancy
Obesity and overweight in adulthood have been reported to be associated with important reductions in life expectancy. Data from the longitudinal Framingham Heart Study were analysed to assess the implications of obesity (as measured Figure 4 Risk of Alzheimer's disease in elderly patients, with or without the metabolic syndrome (adapted from Vanhanen et al. 17 ).
by BMI) at age 40 on life expectancy. The analysis showed that for 40-year-old non-smokers (without previously diagnosed cardiovascular disease) obesity was associated with 7.1 years of life lost in women and 5.8 years of life lost in men, compared with people of normal weight at age 40. The difference between men and women was not statistically significant, but the trend to increased effect for women was of interest.
With the double burden of obesity and smoking, obese women who smoked lost 13.3 years and obese male smokers lost 13.7 years compared with non-smokers of normal weight. 21 
Summary
Obesity has negative consequences for women's health throughout the life cycle, with important psychosocial, economic and biologic implications. In addition, obesity in women has the potential to have an intergenerational impact if overweight and obese mothers transmit risk for chronic disease during their pregnancies.
